Compare HRTG & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HRTG | IMTX |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 898.0M | 1.3B |
| IPO Year | 2014 | N/A |
| Metric | HRTG | IMTX |
|---|---|---|
| Price | $26.59 | $10.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $32.50 | $19.25 |
| AVG Volume (30 Days) | 486.8K | ★ 657.4K |
| Earning Date | 11-05-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 98.61 | N/A |
| EPS | ★ 4.83 | N/A |
| Revenue | ★ $842,277,000.00 | $99,445,031.00 |
| Revenue This Year | $5.45 | N/A |
| Revenue Next Year | $7.27 | $24.39 |
| P/E Ratio | $5.53 | ★ N/A |
| Revenue Growth | ★ 6.12 | N/A |
| 52 Week Low | $9.89 | $3.30 |
| 52 Week High | $31.98 | $12.41 |
| Indicator | HRTG | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.55 | 51.02 |
| Support Level | $27.15 | $9.76 |
| Resistance Level | $28.78 | $12.41 |
| Average True Range (ATR) | 1.42 | 0.87 |
| MACD | -0.30 | 0.01 |
| Stochastic Oscillator | 13.62 | 36.85 |
Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.